Spectral Medical (EDT) Competitors C$0.82 0.00 (0.00%) As of 04/17/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock EDT vs. AKU, GEN, LMD, LXG, SQD, DXD, MBI, BUX, CRL, and NBLYShould you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Akumin (AKU), GeneNews (GEN), LED Medical Diagnostics (LMD), LexaGene (LXG), SQI Diagnostics (SQD), 3D Signatures (DXD), Med Biogene (MBI), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), and Neighbourly Pharmacy (NBLY). These companies are all part of the "medical" sector. Spectral Medical vs. Akumin GeneNews LED Medical Diagnostics LexaGene SQI Diagnostics 3D Signatures Med Biogene Biomark Diagnostics Charles River Laboratories International Neighbourly Pharmacy Spectral Medical (TSE:EDT) and Akumin (TSE:AKU) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Do insiders & institutionals have more ownership in EDT or AKU? 13.0% of Spectral Medical shares are held by institutional investors. Comparatively, 30.3% of Akumin shares are held by institutional investors. 18.2% of Spectral Medical shares are held by insiders. Comparatively, 33.0% of Akumin shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is EDT or AKU more profitable? Spectral Medical has a net margin of 0.00% compared to Akumin's net margin of -34.67%. Akumin's return on equity of -483.86% beat Spectral Medical's return on equity.Company Net Margins Return on Equity Return on Assets Spectral MedicalN/A -973.97% -93.22% Akumin -34.67%-483.86%0.47% Does the media favor EDT or AKU? In the previous week, Spectral Medical had 1 more articles in the media than Akumin. MarketBeat recorded 1 mentions for Spectral Medical and 0 mentions for Akumin. Spectral Medical's average media sentiment score of 0.00 equaled Akumin'saverage media sentiment score. Company Overall Sentiment Spectral Medical Neutral Akumin Neutral Which has stronger earnings and valuation, EDT or AKU? Spectral Medical has higher earnings, but lower revenue than Akumin. Spectral Medical is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectral MedicalC$1.90M121.38-C$18.68M-C$0.07-11.71AkuminC$737.69M0.00-C$255.80M-C$3.80N/A Which has more volatility & risk, EDT or AKU? Spectral Medical has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, Akumin has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500. Does the MarketBeat Community believe in EDT or AKU? Spectral Medical received 106 more outperform votes than Akumin when rated by MarketBeat users. Likewise, 65.17% of users gave Spectral Medical an outperform vote while only 64.10% of users gave Akumin an outperform vote. CompanyUnderperformOutperformSpectral MedicalOutperform Votes13165.17% Underperform Votes7034.83% AkuminOutperform Votes2564.10% Underperform Votes1435.90% SummarySpectral Medical beats Akumin on 7 of the 13 factors compared between the two stocks. Get Spectral Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EDT vs. The Competition Export to ExcelMetricSpectral MedicalDiagnostics & Research IndustryMedical SectorTSE ExchangeMarket CapC$230.63MC$747.25MC$5.31BC$5.54BDividend Yield1.45%5.44%5.45%6.44%P/E Ratio-11.711.9021.9429.97Price / Sales121.38439.06380.66584.95Price / Cash82.5011.4238.2583.35Price / Book-10.252.766.453.54Net Income-C$18.68MC$308.37BC$3.22BC$301.19M7 Day Performance10.81%13.21%0.74%2.14%1 Month Performance15.49%0.36%-9.66%-3.43%1 Year Performance86.36%-8.48%11.81%10.96% Spectral Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EDTSpectral MedicalN/AC$0.82flatN/A+86.4%C$230.63MC$1.90M-11.7129AKUAkuminN/AN/AN/AN/AC$37.20MC$737.69M-0.141,527GENGeneNewsN/AN/AN/AN/AC$25.49MC$234,592.00-2.212,700LMDLED Medical DiagnosticsN/AC$0.40+∞N/A+0.0%C$15.51MC$14.96M-10.2646Gap UpLXGLexaGeneN/AC$0.11-19.2%N/A+0.0%C$14.77MC$110,927.00-1.3141High Trading VolumeSQDSQI DiagnosticsN/AC$0.02flatN/A+0.0%C$6.11MC$3.04M-0.30147,000Gap UpDXD3D SignaturesN/AC$0.04+∞N/A+0.0%C$2.66MN/A-0.91N/AGap UpMBIMed BiogeneN/AC$0.05-18.2%N/A+0.0%C$597,000.00N/A-7.5080Gap DownBUXBiomark DiagnosticsN/AN/AN/AN/A$0.00N/A0.00N/APositive NewsGap DownHigh Trading VolumeCRLCharles River Laboratories InternationalN/AN/AN/AN/A$0.00N/A0.0021,400Gap DownNBLYNeighbourly PharmacyN/AN/AN/AN/AC$835.51MC$874.61M-25.483,648High Trading Volume Related Companies and Tools Related Companies Akumin Competitors GeneNews Competitors LED Medical Diagnostics Competitors LexaGene Competitors SQI Diagnostics Competitors 3D Signatures Competitors Med Biogene Competitors Biomark Diagnostics Competitors Charles River Laboratories International Competitors Neighbourly Pharmacy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:EDT) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectral Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.